Pharvaris NV

PHVSStocksBiotechnologyNetherlandsNasdaqUSD

Price

$32.96

Today

-0.2%

YTD

+19.4%

About

Pharvaris NV is a pharmaceutical firm acclaimed for its innovative approach to treating Hereditary Angioedema (HAE), which impacts thousands of people globally. Embedding transformational science in its operations, it operates primarily in the United States and Europe, catering to a diverse population. Pharvaris operates in the pharmaceutical industry, which is an essential part of the healthcare sector. It provides innovative drug advancements focused primarily on B2-receptor antagonist small molecules for the treatment of bradykinin-mediated diseases. Keep up to date on the latest share price changes by adding PHVS stock to your eToro watchlist.

Price chart

Closing price history for PHVS (1D candles).

No daily candle data is currently available for this instrument.

Open positions

Current open positions for this instrument from your live portfolio.

Open positions

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-11.04

P/S (TTM)0.00

P/B (TTM)8.43

Market cap$2.45B

Cap tierMid-cap

Industry avg P/E-6.22

Profitability

Gross marginUnknown

EBIT margin0.00%

Net marginUnknown

ROE-75.71%

ROA-68.82%

Earnings & Revenue

Revenue (TTM)$0.00

Revenue growth (1Y)Unknown

EPS (TTM)-$3.18

Free cash flow$-176.19M

Total debt$851,350.21

Dividends & Risk

Dividend rate$0.00

Dividend yield0.00%

Beta (5Y)0.75

Employees129

Next earnings12 Nov '26

Trade history

Closed trades

Realized return

+0.0%

No stored closed trades exist for this instrument yet.